Thu.Aug 17, 2023

article thumbnail

Video: Generative AI and the Future of Health Care, Part 1

Drug Topics

How can Generative AI might improve the health care retail space?

247
247
article thumbnail

How an AstraZeneca exec is leading the charge in the next immuno-oncology era

PharmaVoice

The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Video: Generative AI and the Future of Health Care, Part 2

Drug Topics

What are some potential applications for Generative AI in the healthcare space?

247
247
article thumbnail

A leading Democrat reveals how his mental health struggles shape his policy approach

PharmaVoice

Seattle Congressman Adam Smith's journey with anxiety and chronic health has influenced his perspective on healthcare and pharmaceutical policy.

246
246
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

RPhCast, Episode Four: Finding Satisfaction In A Pharmacy Career

Drug Topics

Kevin is joined by Dr. Thea Blystone, PharmD for a talk about finding fulfillment and satisfaction in the pharmacy world, plus how to find balance between serving others and having time for yourself.

247
247
article thumbnail

Experts Discuss "Cosmetics With Cause," Empowering Women

Pharmacy Times

Experts Christina Madison, PharmD, FCCP, AAHIVP, and Joy Hoover, founder of Esōes Cosmetics, sat down to discuss how cosmetics can empower users of all genders.

123
123

More Trending

article thumbnail

Vermont’s Prescribed Products Gift Ban and Disclosures Act

Pharmacy Times

The law has impacted the number of physicians receiving payment from drug companies.

123
123
article thumbnail

How AI Can Improve Controlled Substance Security

Drug Topics

Each year, drug diversion is estimated to cost the US health care system an estimated $70 billion. Outside of these costs, drug diversion poses a significant risk to patient safety and patient’s communities.

article thumbnail

Receiving SARS-CoV-2 Booster During Pregnancy May Improve Newborn’s Immune Responses to Virus

Pharmacy Times

A COVID-19 booster dose increased both maternal and cord blood binding and neutralizing antibody levels against virus strains, including Omicron BA.1.

article thumbnail

2022 Roger F. Sherwood Article of the Year Award Finalists Announced

ISPE

2022 Roger F. Sherwood Article of the Year Award Finalists Announced Trudy Patterson Thu, 08/17/2023 - 11:22 iSpeak Blog iSpeak 2022 Roger F. Sherwood Article of the Year Award Finalists Announced ISPE 17 August 2023 Pharmaceutical Engineering ® is delighted to announce the finalists for the 2022 Roger F. Sherwood Article of the Year Award. The articles were selected by judges of 36 feature and technical articles published in Pharmaceutical Engineering during the 2022 calendar year (Volume 42).

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Study: Healthy, Born-at-Term Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infections Need Intensive Care

Pharmacy Times

The findings of the study demonstrate the need for preventive interventions for all infants in order to reduce the burden of severe illness from respiratory syncytial virus lower respiratory tract infections.

123
123
article thumbnail

New definition of a human embryo proposed amid rapid scientific advances

STAT

When someone says the word embryo, what do you think of? Probably that picture you’ve seen a thousand times on a thousand different news articles: a translucent orb swelling with cytoplasm being prodded by a microinjection needle under the light of a microscope. The mainstreaming of IVF, or in vitro fertilization, has familiarized new generations of people with what the earliest stages of human development entails.

98
article thumbnail

After Adjusting for Social Determinants of Health, Cardiovascular Disease Mortality Differences Disappear Between Black, White Populations

Pharmacy Times

Adjustments for social determinants of health in the US population had a significant impact on cardiovascular disease mortality data between Black and White populations.

123
123
article thumbnail

STAT+: South Africa ordered to disclose contracts with Pfizer, J&J, and other Covid-19 vaccine suppliers

STAT

A South African court ruled the government must disclose contracts signed with pharmaceutical companies for Covid-19 vaccines, a victory for advocates who alleged that authorities may have overpaid for the shots and that the lack of transparency masked pharmaceutical profits at the public’s expense. At issue are contracts signed by the South African government with several companies — including Johnson & Johnson and Pfizer — that provided millions of Covid-19 vaccines du

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Biosimilar Aflibercept Shows Positive Efficacy and Safety Results in Confirmatory Study

Pharmacy Times

The Mylight phase 3 trial confirmed that there was no clinically meaningful differences between aflibercept and its reference biologic, Eylea, for patients with wet macular degeneration.

123
123
article thumbnail

Stanford Health CEO David Entwistle joins Redesign Health's board. Here's why he's bullish on digital health

Fierce Healthcare

David Entwistle has a storied career as a healthcare executive leading new innovations and steering strategic growth at academic medical centers. | Stanford Health Care CEO David Entwistle joined the board of directors at New York City-based Redesign Health. Here are the areas of healthcare he thinks are ripe for innovation.

98
article thumbnail

STAT+: U.S. appeals court strikes down key provisions in Oklahoma law that regulates PBMs

STAT

A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate the retail networks created by pharmacy benefit managers, dealing a setback to efforts to curtail the dominant role these controversial middlemen play in the pharmaceutical supply chain. The Pharmaceutical Care Management Association, a trade group for pharmacy benefit managers that sued to block the law, objected to Oklahoma’s attempt to “interfere” with efforts to administer health plans tha

98
article thumbnail

Blue Shield of California ditches CVS Caremark as PBM, unveils new pharmacy care model

Fierce Healthcare

Blue Shield of California today unveiled a new model for pharmacy care that it hopes will overhaul the “broken prescr | Blue Shield of California hopes to cut prescription drugs costs between 10% and 15%, or about $500 million a year, with an ambitious program that sidesteps the pharmacy benefit manager.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Opinion: Medicare beneficiaries deserve access to genetic counselors

STAT

Precision medicine driven by genetic health care is knocking on the door. It offers hope that, sooner than later, we can address health problems like Alzheimer’s disease, cancer, and heart disease that affect the lives of so many Americans. For many patients, the first step will be genetic testing and counseling by a board-certified genetic counselor.

98
article thumbnail

Seniors believe Medicare needs overhaul but still feel entitled to current benefits

Fierce Healthcare

A recent survey from eHealth, an independent Medicare insurance adviser, released new data that shows 84% of respondents believe Medicare needs reform, but just 12% think changes should impact thei | A new survey shows that while seniors acknowledge Medicare reform is critical to the program's future, they expect to receive benefits at the cost they were promised.

article thumbnail

Listen: Racing for gene therapy, a pioneering approval, & startups in the lurch

STAT

What difference does a day make? Who gets to have gene therapy? And are biotech startups OK? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays.

98
article thumbnail

HOPCo Network Solutions partners with Florida value-based care network

Fierce Healthcare

Healthcare Outcomes Performance Company, a national leader in musculoskeletal practice and clinical outcomes management solutions, has partnered with Provider Network Solutions to establish a joint | Under a new joint venture with Provider Network Solutions (PNS) in Florida, HOPCo Network Solutions will add 1,100 new orthopedic, pain management and podiatry partners.

98
article thumbnail

Opinion: The definition of clinical trial diversity must include disabled people

STAT

There are people in your life who influence and shape how you see the world. For me, one of these people is Terry Moakley, a warm and welcoming family friend, a veteran of the Vietnam War, and a fervent advocate for people with disabilities. After he became a quadriplegic as a result of an injury, he began a decades-long career dedicated to improving disability access.

98
article thumbnail

Mayo Clinic up nearly $1B as of 2023's midyear mark thanks to 'overperformance' of core operations

Fierce Healthcare

Mayo Clinic built on its solid first quarter with an even stronger $300 million fro | The nonprofit's six-month revenues are up 9.8% year over year, outpacing an 8.2% rise in expenses. For the second quarter, management attributed its nearly $4.5 billion total revenue to “overperformance in core operations as well as positive investment returns.

article thumbnail

UK sets aside £210m for antimicrobial resistance project

pharmaphorum

UK sets aside £210m for antimicrobial resistance project Phil.

98
article thumbnail

EDs are drowning under a rising number of pediatric behavioral health patients, providers warn

Fierce Healthcare

Amid warnings that emergency departments are not fully equipped to meet rising mental and behavioral health (MBH) needs of minors, a trio of healthcare professional organizations is calling for mor | Recent years have cemented emergency departments as critical access points and safety net care providers for kids with mental and behavioral health conditions.

98
article thumbnail

STAT+: Blue Shield of California overhauls drug pricing operation — by adding more vendors

STAT

Blue Shield of California, a health insurance company that covers almost 5 million people, is restructuring how it will pay for prescription drugs by dividing the work up among five different vendors — two of which include Amazon and Mark Cuban’s pharmacy company. Starting in 2024, Blue Shield will rely less on CVS Health’s pharmacy benefit manager, CVS Caremark, a move that led Wall Street to sell off CVS’ stock by more than 9%.

article thumbnail

PocketHealth launches in-app tool to surface follow-up instructions, boost compliance among patients

Fierce Healthcare

Pocket Health, a medical image-sharing platform, has launched a tool to help patients stay on top of their follow-up recommendations. | Whether the instructions are to schedule another appointment, tissue sampling or lab work, Follow-Up Navigator will surface them to the patient and prompt them to take action.

98
article thumbnail

CDMO to manufacture SARS-CoV-2 intranasal vaccine

European Pharmaceutical Review

The National Institutes of Health (NIH) has chosen contract development, and manufacturing organisation (CDMO) Exothera SA to develop the manufacturing process for its intranasal vaccine against SARS-CoV-2 coronavirus to treat COVID-19. As an alternative drug delivery method to traditional injected vaccines, live, replicating, intranasal vaccines have potential for effectively interrupting transmission of COVID-19 by inducing the development of immunity in the respiratory tract.

article thumbnail

STAT+: ActiGraph executives on why getting digital endpoints approved for drug trials matters

STAT

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry. The Pensacola, Fla.-based company creates  devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

98
article thumbnail

Meijer invites environmentally-focused suppliers to Sustainability Summit

Drug Store News

The virtual event, held on Oct. 11-13, seeks suppliers with sustainable products in the food, health and beauty, everyday essentials, pet, apparel and general merchandise categories.

98
article thumbnail

STAT+: ViiV Healthcare and Doctors Without Borders tussle over contract terms for an HIV drug

STAT

A feud has erupted between ViiV Healthcare and Doctors Without Borders over a deal to allow the relief organization to purchase an injectable HIV prevention drug, the latest fracas involving the company and efforts to distribute its medication to mostly poor locations around the world. The dispute hinges on a move by the ViiV, which is largely controlled by GSK, to add certain last-minute conditions to a procurement agreement, according to Doctors Without Borders.

98
article thumbnail

Changing Faces: Pharma and biotech hires from July 2023

pharmaphorum

Changing Faces: Pharma and biotech hires from July 2023 Mike.

98